Scott M Schuetze
Clinical Professor of Internal Medicine
Internal Medicine - Hematology/Oncology
1500 E. Medical Center Drive
Ann Arbor, MI 48109
[email protected]

Available to mentor
Scott M Schuetze
Clinical Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial.
      Mowery YM, Ballman KV, Hong AM, Schuetze SM, Wagner AJ, Monga V, Heise RS, Attia S, Choy E, Burgess MA, Bae S, Pryor DI, Van Tine BA, Tinoco G, Chmielowski B, Freeman C, Gronchi A, Meyer CF, Dickson MA, Hartner L, Davis LE, Powers BC, Moding EJ, Weinhold KJ, van de Rijn M, Brigman BE, Riedel RF, Kirsch DG. Lancet, 2024 Nov 23; 404 (10467): 2053 - 2064. DOI:10.1016/S0140-6736(24)01812-9
      PMID: 39547252
    • Journal Article
      A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.
      Schuetze SM, Ballman KV, Heise R, Ganjoo KN, Davis EJ, George S, Burgess MA, Choy E, Shepard DR, Tinoco G, Hirbe A, Kelly CM, Attia S, Deshpande HA, Schwartz GK, Siontis BL, Riedel RF, von Mehren M, Kozlowski E, Chen HX, Astbury C, Rubin BP. Clin Cancer Res, 2024 Oct 15; 30 (20): 4584 - 4592. DOI:10.1158/1078-0432.CCR-23-3817
      PMID: 38446990
    • Journal Article
      Radiomic-based prediction of lesion-specific systemic treatment response in metastatic disease.
      Geady C, Abbas-Aghababazadeh F, Kohan A, Schuetze S, Shultz D, Haibe-Kains B. Comput Med Imaging Graph, 2024 Sep; 116: 102413 DOI:10.1016/j.compmedimag.2024.102413
      PMID: 38945043
    • Preprint
      Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease.
      Geady C, Abbas-Aghababazadeh F, Kohan A, Schuetze S, Shultz D, Haibe-Kains B. 2024 Aug 13; DOI:10.1101/2023.09.22.23294942
      PMID: 37873411
    • Journal Article
      Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured Interviews.
      Knoerl R, Grandinetti K, Smener L, Doll E, Fecher LA, Henry NL, Karimi Y, Pettit K, Schuetze S, Walling E, Zhang A, Barton D. J Adolesc Young Adult Oncol, 2024 Aug; 13 (4): 665 - 673. DOI:10.1089/jayao.2024.0053
      PMID: 38634665
    • Journal Article
      Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study.
      Schuetze S, Rothe M, Mangat PK, Garrett-Mayer E, Meric-Bernstam F, Calfa CJ, Farrington LC, Livingston MB, Wentzel K, Behl D, Kier Y, Marr AS, von Mehren M, Press JZ, Thota R, Grantham GN, Gregory A, Hinshaw DC, Halabi S, Schilsky RL. JCO Precis Oncol, 2024 Jul; 8: e2400219 DOI:10.1200/PO.24.00219
      PMID: 39013131
    • Journal Article
      Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS).
      Schuetze S. 2024 Jun;
    • Journal Article
      SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma.
      Schuetze S. 2024 Jun;